PAROS

Incepto
PAROS is an Artificial Intelligence Augmented Radiology solution for prostate MRI. It automatically segments the prostate to estimate its volume. The prostate lesions are automatically detected, segmented, characterized and shown in the PIRADS schema with their respective level of suspicion.
incepto-paros
incepto-paros_1
incepto-paros_1
incepto-paros
incepto-paros_1
incepto-paros_1
Information source: Vendor
Last updated: November 6, 2024

General Information

General
Product name PAROS
Company Incepto
Subspeciality Abdomen
Modality MR
Disease targeted Prostate cancer
Key-features Prostate segmentation and volumetrics, lesion detection, segmentation and characterization, PI-RADS support
Suggested use "During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
After: diagnosis verification"

Technical Specifications

Data characteristics
Population Any patient over 18 years old for which a prostate MRI examination has been indicated
Input T2 (axial or 3D), ADC map, Diffusion series with the highest B-value
Input format DICOM
Output Overlay of the segmented prostate and detected lesion(s), heatmap overlay which highlights suspicious areas in the prostate, prefilled report as DICOM SC.
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes

Regulatory

Certification
CE
Certified, IIa , MDR
FDA No or not yet
Intended Use Statements
Intended use (according to CE) PAROS is an image processing software intended to assist the physician's diagnosis for prostate cancer. This medical device software uses prostate MRI examinations in order to automatically provide data about prostate condition and cancerous lesions detection and characterization.

Market

Market presence
On market since 07-2024
Distribution channels Incepto
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription
Based on Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers